Profile
| Metric | Value |
|---|---|
| Full Name | Chemed Corporation |
| Ticker | NYSE: CHE |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | chemed.com |
| Employees | 15,695 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $449.18 | |
| Price, 1D Change | +2.25% | |
| Market Cap | $6B | |
| TTM Dividend Yield | 0.49% | |
| PE Ratio | 23.75 | |
| Beta | 0.26 | |
| Revenue | $2B | |
| Revenue, 1Y Change | +7.37% | |
| EPS | $19.89 | |
| EPS, 1Y Change | +10.92% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.60 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | RRR | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $19.89 | |
| EPS Estimate | $22.19 | |
| EPS Est. Change | +11.58% | |
| Revenue | $2.43B | |
| Revenue Estimate | $2.55B | |
| Revenue Est. Change | +4.87% | |
| Current Price | $449.18 | |
| Price Target | - | $576.00 |
| Price Tgt. Change | - | +28.23% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $21.10 | $17.93 | -15.03% | |
| $23.08 | $19.89 | -13.84% | |
| $22.19 | N/A | +11.58% | |
| $25.48 | N/A | +28.11% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.26B | $2.26B | -0.00% | |
| $2.43B | $2.43B | +0.16% | |
| $2.55B | N/A | +4.87% | |
| $2.71B | N/A | +11.36% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -15.57% | |
| Price, 3Y | -8.99% | |
| Market Cap, 1Y | -18.17% | |
| Market Cap, 3Y | -13.67% | |
| Revenue, 1Y | +7.37% | |
| Revenue, 3Y | +13.65% | |
| EPS, 1Y | +10.92% | |
| EPS, 3Y | +18.02% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $449.18 | |
| SMA 200 | $487.08 | |
| SMA 200 vs Price | +8.44% | |
| SMA 50 | $435.00 | |
| SMA 50 vs Price | -3.16% | |
| Beta | 0.26 | |
| ATR | $9.68 | |
| 14-Day RSI | 62.97 | |
| 10-Day Volatility | 22.88% | |
| 1-Year Volatility | 29.76% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.60 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 0.40% | |
| Total Dividend | $1.80 | |
| Dividends Paid | $27.09M | |
| Payout Ratio | 8.97% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $2.43B | |
| EPS | $19.89 | |
| Gross Profit | $791.30M | |
| Gross Margin | 32.55% | |
| Operating Profit | $372.96M | |
| Operating Margin | -52.11% | |
| Net Income | $302.00M | |
| Net Margin | 12.42% | |
| EBITDA | $436.01M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.13 | |
| Current Ratio | 1.38 | |
| Quick Ratio | 1.35 | |
| - | ||
| F-Score | 7 | |
| Altman Z-Score | 10.17 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 23.75 | |
| PS Ratio | 2.50 | |
| PB Ratio | 5.89 | |
| EV/EBITDA | 15.28 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $1.12B | |
| Cash & Equivalents | $178.35M | |
| Total Assets | $1.77B | |
| Current Assets | $394.75M | |
| Total Liabilities | $648.37M | |
| Current Liabilities | $285.70M | |
| Total Debt | $140.84M | |
| Short Term Debt | $42.31M | |
| Accounts Payable | $44.15M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $2.13B | |
| Operating Expenses | $418.34M | |
| Cost Of Goods Sold | $1.64B | |
| SG&A | $0.00 | |
| D&A | $63.05M | |
| Interest Expense | $0.00 | |
| Income Tax | $97.47M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $417.50M | |
| CFI | -$143.91M | |
| CFF | -$359.19M | |
| Capex | $49.53M | |
| Free Cash Flow | $367.97M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| RBC Capital | → | |
| B of A Securities | → | |
| Jefferies | → | |
| RBC Capital | → | |
| Oppenheimer | → | |
| Jefferies | ||
| RBC Capital | → | |
| B of A Securities | → | |
| RBC Capital | → | |
| RBC Capital | → |
Analyst sentiment
Institutional ownership
Screeners with CHE
Data Sources & References
- CHE Official Website www.chemed.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/19584/000001958425000004/0000019584-25-000004-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/19584/000156276225000038/0001562762-25-000038-index.htm
- CHE Profile on Yahoo Finance finance.yahoo.com/quote/CHE
- CHE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/che
FAQ
What is the ticker symbol for Chemed Corporation?
The ticker symbol for Chemed Corporation is NYSE:CHE
Does Chemed Corporation pay dividends?
Yes, Chemed Corporation pays dividends. The last payment was $0.60, with an ex-dividend date on November 17, 2025
What sector is Chemed Corporation in?
Chemed Corporation is in the Healthcare sector
What industry is Chemed Corporation in?
Chemed Corporation is in the Medical Care Facilities industry
What country is Chemed Corporation based in?
Chemed Corporation is headquartered in United States
When did Chemed Corporation go public?
Chemed Corporation initial public offering (IPO) was on May 3, 1973
Is Chemed Corporation in the S&P 500?
No, Chemed Corporation is not included in the S&P 500 index
Is Chemed Corporation in the NASDAQ 100?
No, Chemed Corporation is not included in the NASDAQ 100 index
Is Chemed Corporation in the Dow Jones?
No, Chemed Corporation is not included in the Dow Jones index
When was Chemed Corporation last earnings report?
Chemed Corporation's most recent earnings report was on October 28, 2025
When does Chemed Corporation report earnings?
The next expected earnings date for Chemed Corporation is February 25, 2026
